MBOT Microbot Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MBOT

Price (delayed)

$0.9846

Market cap

$14.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.05

Enterprise value

$11.89M

Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary ...

Highlights
Microbot Medical's debt has plunged by 50% YoY and by 6% from the previous quarter
Microbot Medical's EPS has increased by 42% YoY and by 13% QoQ
MBOT's quick ratio has plunged by 69% from the previous quarter and by 58% YoY
The equity has decreased by 39% QoQ and by 38% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.microbotmedical.com
Peers: NWBO

Key stats

What are the main financial stats of MBOT
Market
Shares outstanding
14.4M
Market cap
$14.18M
Enterprise value
$11.89M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.56
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$10.74M
EBITDA
-$10.63M
Free cash flow
-$8.57M
Per share
EPS
-$1.05
Free cash flow per share
-$0.84
Book value per share
$0.38
Revenue per share
$0
TBVPS
$0.82
Balance sheet
Total assets
$8.33M
Total liabilities
$3.83M
Debt
$231,000
Equity
$4.5M
Working capital
$4.14M
Liquidity
Debt to equity
0.05
Current ratio
2.09
Quick ratio
1.7
Net debt/EBITDA
0.21
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-125.2%
Return on equity
-164.1%
Return on invested capital
-272%
Return on capital employed
-236.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MBOT stock price

How has the Microbot Medical stock price performed over time
Intraday
-0.55%
1 week
11.89%
1 month
-21.86%
1 year
-9.67%
YTD
-39.96%
QTD
-19.95%

Financial performance

How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.86M
Net income
-$10.74M
Gross margin
N/A
Net margin
N/A
MBOT's operating income is up by 26% year-on-year and by 9% since the previous quarter
MBOT's net income is up by 18% year-on-year

Growth

What is Microbot Medical's growth rate over time

Valuation

What is Microbot Medical stock price valuation
P/E
N/A
P/B
2.56
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Microbot Medical's EPS has increased by 42% YoY and by 13% QoQ
The equity has decreased by 39% QoQ and by 38% YoY
The stock's price to book (P/B) is 16% less than its last 4 quarters average of 3.1 and 13% less than its 5-year quarterly average of 3.0

Efficiency

How efficient is Microbot Medical business performance
The company's return on invested capital rose by 41% YoY but it fell by 22% QoQ
The ROE has contracted by 12% from the previous quarter and by 2.8% YoY
MBOT's return on assets is down by 5% since the previous quarter but it is up by 2.1% year-on-year

Dividends

What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBOT.

Financial health

How did Microbot Medical financials performed over time
The total assets is 118% higher than the total liabilities
MBOT's total liabilities has surged by 150% since the previous quarter and by 70% year-on-year
MBOT's quick ratio has plunged by 69% from the previous quarter and by 58% YoY
Microbot Medical's debt is 95% less than its equity
Microbot Medical's debt to equity has surged by 67% QoQ but it has decreased by 17% YoY
Microbot Medical's debt has plunged by 50% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.